Itamar Medical to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on Tuesday, March 2, 2021

Rhea-AI Summary

Itamar Medical Ltd. (NASDAQ: ITMR) will release its financial results for Q4 and FY 2020 on March 2, 2021, before U.S. market opening. The company provides a digital health platform for sleep apnea management integrated into cardiac care. The results will be discussed in a conference call at 8:00 a.m. ET, hosted by CEO Gilad Glick and CFO Shy Basson. Itamar is focused on non-invasive medical devices for diagnosing sleep disorders, offering its key product, WatchPAT, in major markets such as the U.S., Japan, and Europe.

Positive

• The upcoming financial results may provide insights into growth metrics for Itamar Medical.
• Itamar Medical's digital healthcare platform aids in enhancing patient care while potentially reducing healthcare costs.

Negative

• None.

CAESAREA, Israel, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, announced today that it will report its financial results for the fourth quarter and full year 2020 before the U.S. market opens on Tuesday, March 2, 2021.

The Company will host a conference call that day at 8:00 a.m. Eastern Time, 3:00 p.m. Israel Time to review financial results and provide a corporate update. The call will be hosted by Gilad Glick, President and CEO, and Shy Basson, CFO.

To listen live via webcast, please visit https://edge.media-server.com/mmc/p/s5e4jez2

To participate via phone, please use the following dial in information:
U.S. toll-free: 1-833-519-1272
International: 1-914-800-3844
Israel toll-free: 1-809-457-877
Conference ID: 2555526

Please log in approximately 10 minutes prior to the scheduled start time. The archived webcast will be available in the Events and Presentations section of the Company’s website for at least 60 days following the call.

About Itamar Medical Ltd.
Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders. Itamar Medical commercializes a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets. Itamar Medical offers a Total Sleep Solution to help physicians provide comprehensive sleep apnea management in a variety of clinical environments to optimize patient care and reduce healthcare system costs. The Company’s key product, WatchPAT, is commercially available within major markets including the US, Japan, and Europe. Itamar Medical is a public company traded on the Nasdaq and on the Tel Aviv Stock Exchanges, and is based in Caesarea, Israel with U.S. headquarters based in Atlanta, GA. For additional information visit www.itamar-medical.com

Itamar Medical Investor Relations Contact (U.S.)
Leigh Salvo
Gilmartin Group
Phone: +1-415-937-5412
investors@itamar-medical.com

FAQ

When will Itamar Medical report its financial results for Q4 2020?

Itamar Medical will report its financial results on March 2, 2021, before the U.S. market opens.

What time is the conference call for Itamar Medical's financial results?

The conference call will be held at 8:00 a.m. Eastern Time on March 2, 2021.

What is the focus of Itamar Medical's business?

Itamar Medical focuses on the development of non-invasive medical devices for diagnosing sleep disorders.

What is Itamar Medical's key product?

The key product of Itamar Medical is WatchPAT, designed for sleep apnea management.

Where can I listen to the conference call for Itamar Medical?

The conference call can be accessed via a live webcast or by phone, with details provided in the press release.